Skip to main content
logo
Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0970
+0.0050 (5.43%)
Aug 7, 2026, 3:59 PM AEST

Rhythm Biosciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
1.653.191.693.12.431.11
Revenue Growth
-48.38%88.85%-45.41%27.54%118.98%1008.51%
Gross Profit
1.012.97-1.363.12.431.11
Operating Income
-6.6-3.73-6.91-8.44-8.82-6.62
Net Income
-6.68-3.83-6.86-8.22-8.79-6.61
Earnings Per Share
-0.02-0.01-0.03-0.04-0.04-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
1.731.480.754.177.62.27
Total Debt
0.261.110.160.080.17-
Net Cash (Debt)
1.470.370.594.087.432.27
Net Cash Growth
290.96%-36.52%-85.54%-44.99%226.62%26.26%
Net Cash Per Share
0.000.000.000.020.040.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-6.11-2.92-6.14-6.96-6.5-5.4
Capital Expenditures
-0.02-0.02-0.08-0.1-0.03-0.07
Free Cash Flow
-6.14-2.94-6.22-7.06-6.52-5.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
61.47%92.95%-80.31%100.00%100.00%100.00%
Operating Margin
-400.74%-116.85%-408.60%-272.60%-363.29%-597.64%
Pretax Margin
-405.14%-119.97%-405.69%-265.44%-362.26%-596.49%
Profit Margin
-405.14%-119.97%-405.69%-265.44%-362.26%-596.49%
FCF Margin
-372.52%-92.25%-367.98%-227.94%-268.74%-493.52%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
20.834.819.1229.11101.42161.41